58 research outputs found
IN VITRO AND IN VIVO STUDIES OF THE IMMUNE RESPONSE TO SHEEP ERYTHROCYTES USING PARTIALLY PURIFIED CELL PREPARATIONS
The BSA density-gradient technique for separating mouse spleen cells into partially purified populations has been used to compare the responsiveness of such populations to SRBC using in vivo and in vitro techniques. Two major populations were distinguished, one of which responded very well in vivo with an exponential dose response and poorly in vitro (fraction 3), and another which responded in vivo and in vitro with a linear dose response (fraction 2). A light density, radiation-resistant component was identified which markedly stimulated the response of fraction 3 in vitro, and a density gradient profile was obtained for this cell which did not correspond with a macrophage profile. A high density, radiation-sensitive cell was identified which stimulated the response of PFC precursors in lighter regions of the gradient. The activity of this cell could be replaced using thymus cells. A density profile for the PFC precursor cell was obtained by assaying small numbers of spleen cell fractions in the presence of an excess of the two auxiliary cell types
Foci of proliferating antibody-producing cells in a primary immune response in vitro
Spleen cells from normal unimmunized mice were grown with sheep erythrocytes in liquid medium over agar. Proliferating haemolysin-forming cells appeared in these cultures. As the top layer of agar contained sheep erythrocytes, foci of antibody-forming cells could be detected by the areas of haemolysis they produced in the agar
In vitro immunity to sheep erythrocytes by fractionated spleen cells, differentiation within the antibody-forming-cell precursor population.
The haemolytic plaque reduction technique to measure cytotoxicity with hybridoma cells as a target.
The in vitro response to sheep erythrocytes by mouse spleen cells, segregation of distinct events leading to antibody formation.
The clonal analysis of cytotoxic lymphocytes against 2,4,6-trinitrophenyl (tnp)-modified cells.
- …